Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Hastings David C
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Arbutus Biopharma Corp
Entasis Therapeutics Holdings Inc.
Incyte Corp
Notable Labs, Ltd.
SCYNEXIS, Inc.
Unilife Corp
Incyte Corp
Chief Financial Officer
Avg. Two Year Performance
220%
Avg. Purchase Return
79%
Compound
(58%)
Avg. Sale Return
(26%)
Compound
Holdings:
8.5K
shares
Last Three Months: 03-Feb-24 -- 02-May-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
03-May-22 -- 02-May-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions